Taiwan Fda Approves Chugais Actemra To Treat Covid-19 In Hospitalized Adults
By, Admin1 min read
Share
Chugai Pharmaceutical Co., Ltd. Announced That Chugai Pharma Taiwan Ltd., A Wholly-Owned Subsidiary Of Chugai, Obtained An Import Drug License From The Taiwan Food And Drug Administration (Tfda) For Chugai
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
